Human ehrlichioses - 01/09/11
Doi : 10.1016/S0025-7125(03)00093-2
Juan P Olano, MD, David H Walker, MD ⁎ 
Department of Pathology, University of Texas Medical Branch, Galveston, Texas USA
Address reprint requests to: David H. Walker, MD University of Texas Medical Branch 301 University Boulevard, Keiller Building Galveston, TX 77555-0609Résumé |
Human ehrlichioses are bacterial, tick-borne, newly emergent infectious diseases. The first human case of ehrlichiosis in the United States was described in 1987. The knowledge of these infectious diseases is still evolving even though they have been known as veterinary pathogens for almost a century. Diagnosis remains a challenge due to the nonspecific nature of clinical signs and symptoms. Indirect immunofluorescence assay serology is the gold standard for diagnosis. Tetracyclines are the drug of choice for treatment of human ehrlichioses.
Le texte complet de cet article est disponible en PDF.Plan
© 2002
W.B. Saunders Company. Tous droits réservés.
Vol 86 - N° 2
P. 375-392 - mars 2002 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?